CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

Natural Alternatives International, Inc. Announces Fiscal 2026 Q4 and YTD Results

EarningsNegative
AI Analysis

Summary

Natural Alternatives International reported a net loss of $13.5 million ($2.23 per diluted share) on net sales of $34.5 million for Q4 FY2026, including a $10.4 million non-cash impairment charge related to underutilization of its Carlsbad manufacturing facility.

Financial Highlights

Revenue

$34.5 million

EPS

($2.23) per diluted share

Importance:3/10
Sentiment:
-0.70
earningsnet lossQ4 FY2026impairment chargemanufacturing facility
Related Companies

Read the original article

Published by GlobeNewswire Pharma on September 28, 2026 8:30 PM

Read Original